Skip to main content

Table 3 Summary statistics regarding numbers of participants by funding source

From: How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?

Parameter Public Private Combined Total
Number of trials (N) 19 289 36 344
Number of participants     
   ≥100,000 0 2 0 2
   30,000-99,999 1 4 1 6
   10,000-29,999 1 38 3 42
   3,000-9,999 6 51 11 68
   1,000-2,999 6 88 11 105
   < 999 5 106 10 121
Mean 4,696 5,944 4,703 5,745
Standard deviation 8,877 21,485 7,299 19,934
Median 2,331 1,400 2,450 1,555
Max 39,876 300,000 40,000 300,000